Inhibrx Biosciences Inc.

NASDAQ: INBX · Real-Time Price · USD
23.44
-0.50 (-2.09%)
At close: Aug 15, 2025, 3:59 PM
23.33
-0.47%
After-hours: Aug 15, 2025, 04:34 PM EDT

Inhibrx Biosciences Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
0.13 -7.42 -6.8 -20.3
PEG Ratio
-0.00 -0.18 -0.1 0.72
PS Ratio
1.11K 994.97 450.85 232.97
PB Ratio
1.67 41.17 17.02 31.69
P/FCF Ratio
-1.13 -9.05 -8.52 -20.45
P/OCF Ratio
-1.15 -9.26 -8.57 -20.67
OCF/S Ratio
-972.04 -107.39 -52.6 -11.27
Debt / Equity Ratio
0.06 4.83 3.57 1.47
Quick Ratio
3.94 5.25 10.18 6.23
Current Ratio
3.94 5.25 10.17 6.20
Asset Turnover
0.00 0.01 0.01 0.05
Interest Coverage
-24.57 -6.89 -8.02 -14.68
Return on Equity
12.63 -5.55 -2.5 -1.56
Return on Assets
9.34 -0.78 -0.5 -0.54
Return on Invested Capital
-2.34 -0.86 -0.48 -0.59
Dividend Yield
0.06 n/a n/a n/a
Payout Ratio
0.01 n/a n/a n/a
Gross Profit Margin
-10.43 0.34 -49.27 0.62
Net Profit Margin
8.44K -134.09 -66.25 -11.48
Pretax Profit Margin
8.44K -133.18 -66.25 -11.48
Operating Profit Margin
-1.66K -121.79 -58.9 -10.75
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
8.52K -114.83 -57.4 -10.58